Sponsor:
University of Florida
Code:
NCT06254326
Conditions
Recurrent Oligodendroglioma
Progressive Oligodendroglioma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
TTRNA-DC vaccines with GM-CSF
Autologous Hematopoietic Stem cells (HSCs)
TTRNA-xALT
Td vaccine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-16. This information was provided to ClinicalTrials.gov by University of Florida on 2025-03-04.